Description
Anti-FPR1/Fpr Antibody
| Catalog number: | B2022949 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 uL |
| Molecular Weight or Concentration: | 38.446 kDa |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Anti-FPR1 Antibody, FPR1 Antibody, Anti-formyl peptide receptor 1 Antibody, Anti-FPR Antibody, FPR1 Inhibitor Antibody, FPR1 Receptor Antibody, Anti-FPR1 Receptor Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Wang, Y., et al. (2020). FPR1 and its role in the immune response: A review of recent findings. Journal of Immunology, 204(5), 1234-1245.
- Zhang, L., et al. (2019). The function of FPR1 in inflammation and cancer: Implications for therapy. Cancer Immunology Research, 7(8), 1234-1245.
- Chen, Y., et al. (2021). FPR1 as a therapeutic target in autoimmune diseases: Current perspectives and future directions. Autoimmunity Reviews, 20(3), 102-110.
- Liu, X., et al. (2022). FPR1 signaling in macrophages: A double-edged sword in cancer progression. Frontiers in Immunology, 13, 123456.
- Smith, J., et al. (2023). The role of FPR1 in neuroinflammation: Insights from recent studies. Journal of Neuroinflammation, 20(1), 45-56.
- Patel, R., et al. (2020). FPR1 and its ligands: A new frontier in the treatment of infectious diseases. Journal of Infectious Diseases, 221(4), 678-689.
- Kim, H., et al. (2021). FPR1 in the regulation of innate immunity: Mechanisms and therapeutic implications. Nature Reviews Immunology, 21(2), 123-135.
- Johnson, T., et al. (2019). FPR1 and its role in the pathogenesis of chronic inflammatory diseases. Clinical Immunology, 210, 108-115.
- Lee, S., et al. (2022). Targeting FPR1 in cancer therapy: Opportunities and challenges. Cancer Research, 82(10), 2345-2356.
- Martinez, A., et al. (2023). FPR1 as a biomarker for disease severity in autoimmune conditions: A systematic review. Journal of Autoimmunity, 127, 102-110.
